HR5544Referred to Committee

Ejiao Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-09-23
Introduced
15
Cosponsors
HR
Type

Sponsor

Donald S. Beyer, Jr.
Donald S. Beyer, Jr.
Democrat · VA · Representative
Votes with party: 98.3% (539 recorded votes)

Full profile: /officials/B001292

Source: Congress.gov · FEC

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Ways and Means, and in addition to the Committees on Natural Resources, Foreign Affairs, Homeland Security, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2025-09-23

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

The bill addresses trade and regulatory issues related to ejiao, a traditional Chinese medicine product made from donkey hides, which has raised concerns about animal welfare, environmental impact, and international trade practices. The legislation would likely establish new rules or restrictions on how ejiao is imported, traded, or used in the United States, affecting companies that sell traditional medicine products and potentially influencing U.S. trade relationships with countries that produce it. The bill's referral to multiple committees suggests it involves complex questions about trade policy, wildlife protection, border enforcement, and legal authority.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Foreign Trade and International Finance
Full bill text is not yet cached locally.